Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Michaela Liedtke, MD, of @StanfordMed, discusses #CARTcell #immunotherapy for #multiplemyeloma.Michaela Liedtke, MD, of @StanfordMed, discusses #CARTcell #immunotherapy for #multiplemyeloma.
Niels van de Donk, MD, PhD, Professor of Cancer Immunology, VU University Medical Center, Amsterdam, Netherlands, discusses #BCMA #CART therapy in #multiplemyeloma.
Part 1 – Case Presentation Welcome to the inaugural episode of the AML Clinical Case Series on The Doctor’s Channel! Gabriel N. Mannis, MD, presents the case of…
